RidhiGuptaMD

Oncology • Valhalla, NY

Physician

Join to view full profile

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gupta's full profile

Already have an account?

Office
95 Grasslands Rd
Munger Pavilion Room 253
Valhalla, NY 10595
Phone+1 914-493-8373

Fax+1 207-621-6102

Education & Training

Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 2017
Westchester Medical CenterResidency, Internal Medicine, 2011 - 2014
Maulana Azad Medical CollegeClass of 2010

Certifications & Licensure

NY State Medical License 2023 - 2025
ME State Medical License 2018 - 2023
CA State Medical License 2017 - 2020
SC State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

485 citations
Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016
Valery L. Feigin, Grant Nguyen, Kelly Cercy, Catherine O. Johnson, Tahiya Alam
The New England Journal of Medicine. 2018-12-20
404 citations
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.
Ujjawal H. Gandhi, Robert F. Cornell, Arjun Lakshman, Zhubin Gahvari, Elizabeth McGehee
Leukemia. 2019-09-01
41 citations
Current management and prognostic features for gastrointestinal stromal tumor (GIST).
Gurpreet Lamba, Ridhi Gupta, Byung Lee, Samir Ambrale, Delong Liu
Experimental Hematology & Oncology. 2012-06-18

Lectures

Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018